Deletions of PURA, at 5q31, and PURB, at 7p13, in myelodysplastic syndrome and progression to acute myelogenous leukemia

被引:0
|
作者
K Lezon-Geyda
V Najfeld
EM Johnson
机构
[1] Biochemistry and Molecular Biology,Departments of Pathology
[2] the Derald H Ruttenberg Cancer Center,undefined
[3] Tumor Cytogenetics Laboratory,undefined
[4] Polly Annenberg Levee Hematology Center,undefined
[5] Mount Sinai School of Medicine,undefined
来源
Leukemia | 2001年 / 15卷
关键词
Pur; MDS; AML; chromosome 5; chromosome 7; haploinsufficiency;
D O I
暂无
中图分类号
学科分类号
摘要
Deletions or monosomy of chromosomes 5 and 7 are frequently observed in myelodysplastic syndromes (MDS) and acute myelogenous leukemia (AML). In this study two genes, PURA and PURB, encoding functionally cooperative proteins in the Pur family, are localized to chromosome bands 5q31.1 and 7p13, respectively. One or both of these loci are shown to be hemizygously deleted in 60 MDS or AML patients using fluorescence in situ hybridization (FISH). High-resolution mapping of PURA localizes it approximately 1.1 Mb telomeric to the EGR-1 gene. Frequency of PURA deletion and segregation with EGR-1 indicate that PURA is within the most commonly deleted segment in myeloid disorders characterized by del(5)(q31). No mutations have been detected within the coding sequence of PURA. Concurrent deletions of PURA and PURB occur in mds at a rate nearly 1.5-fold higher than statistically expected and in aml at a rate >5-fold higher. This novel simultaneous deletion of two closely related gene family members may thus have consequences related to progression to AML. Purα, an Rb-binding protein, has been implicated in cell cycle control and differentiation, and Purα and Purβ are reported to function as heterodimers. Alterations in these genes could affect a delicate balance critical in myeloid development.
引用
收藏
页码:954 / 962
页数:8
相关论文
共 50 条
  • [1] Deletions of PURA, at 5q31, and PURB, at 7p13, in myelodysplastic syndrome and progression to acute myelogenous leukemia
    Lezon-Geyda, K
    Najfeld, V
    Johnson, EM
    LEUKEMIA, 2001, 15 (06) : 954 - 962
  • [2] Deletions of PURA, at 5q31, and PURB, at 7p13 in myelodysplastic syndrome (MDS) and progression to acute myelogenous leukemia (AML).
    Lezon-Geyda, K
    Najfeld, V
    Johnson, EM
    BLOOD, 2000, 96 (11) : 354A - 354A
  • [3] Differences in manifestations of epilepsy and developmental delay in PURA syndrome and 5q31 microdeletions
    Kofoed, Andreas W. S.
    Kristiansen, Silvia S.
    Miranda, Maria J.
    Rubboli, Guido
    Johannesen, Katrine M.
    CLINICAL GENETICS, 2024, 106 (04) : 386 - 393
  • [4] Translocation (11;16) (q23;p13) acute myelogenous leukemia and myelodysplastic syndrome
    Glassman, AB
    Hayes, KJ
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2003, 33 (03): : 285 - 288
  • [5] Genetic analysis of familial myelodysplastic syndrome: Absence of linkage to chromosomes 5q31 and 7q22
    Mandla, SG
    Goobie, S
    Kumar, RT
    Hayne, O
    Zayed, E
    Guernsey, DL
    Greer, WL
    CANCER GENETICS AND CYTOGENETICS, 1998, 105 (02) : 113 - 118
  • [6] Fusion of TEL/ETV6 to a novel ACS2 in myelodysplastic syndrome and acute myelogenous leukemia with t(5;12)(q31;p13)
    Yagasaki, F
    Jinnai, I
    Yoshida, S
    Yokoyama, Y
    Matsuda, A
    Kusumoto, S
    Kobayashi, H
    Terasaki, H
    Ohyashiki, K
    Asou, N
    Murohashi, I
    Bessho, M
    Hirashima, K
    GENES CHROMOSOMES & CANCER, 1999, 26 (03): : 192 - 202
  • [7] Activity of Alemtuzumab in Acute Myelogenous Leukemia and Myelodysplastic Syndrome With Chromosome 7 Aberrations
    Tibes, Raoul
    Noel, Pierre
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (36) : 4841 - 4842
  • [8] Deletion of 5q31 is observed in megakaryocytic cells in patients with myelodysplastic syndromes and a del(5q), including the 5q-syndrome
    Godon, C
    Talmant, P
    Garand, R
    Accart, F
    Bataille, R
    Avet-Loiseau, H
    GENES CHROMOSOMES & CANCER, 2000, 29 (04): : 350 - 352
  • [9] Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion
    Sebaa, Amel
    Ades, Lionel
    Baran-Marzack, Fanny
    Mozziconacci, Marie-Joelle
    Penther, Dominique
    Dobbelstein, Sophie
    Stamatoullas, Aspasia
    Recher, Christian
    Prebet, Thomas
    Moulessehoul, Soraya
    Fenaux, Pierre
    Eclache, Virginie
    GENES CHROMOSOMES & CANCER, 2012, 51 (12): : 1086 - 1092
  • [10] Activity of Alemtuzumab in Acute Myelogenous Leukemia and Myelodysplastic Syndrome With Chromosome 7 Aberrations Reply
    Olnes, Matthew J.
    Scheinberg, Phillip
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (36) : 4842 - 4843